- Home
- TECH vs CRDO Comparison
TECH vs CRDO Comparison
Compare TECH & CRDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- CRDO
- Stock Information
- Founded
- TECH 1976
- CRDO 2008
- Country
- TECH United States
- CRDO Cayman Islands
- Employees
- TECH N/A
- CRDO N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- CRDO Semiconductors
- Sector
- TECH Health Care
- CRDO Technology
- Exchange
- TECH Nasdaq
- CRDO Nasdaq
- Market Cap
- TECH 7.8B
- CRDO 7.3B
- IPO Year
- TECH 1989
- CRDO 2022
- Fundamental
- Price
- TECH $46.78
- CRDO $61.78
- Analyst Decision
- TECH Buy
- CRDO Strong Buy
- Analyst Count
- TECH 10
- CRDO 10
- Target Price
- TECH $73.44
- CRDO $68.00
- AVG Volume (30 Days)
- TECH 2.3M
- CRDO 3.6M
- Earning Date
- TECH 05-07-2025
- CRDO 06-02-2025
- Dividend Yield
- TECH 0.68%
- CRDO N/A
- EPS Growth
- TECH N/A
- CRDO N/A
- EPS
- TECH 0.83
- CRDO 0.03
- Revenue
- TECH $1,208,770,000.00
- CRDO $327,532,000.00
- Revenue This Year
- TECH $7.16
- CRDO $125.51
- Revenue Next Year
- TECH $6.36
- CRDO $58.82
- P/E Ratio
- TECH $56.36
- CRDO $2,049.69
- Revenue Growth
- TECH 4.72
- CRDO 99.38
- 52 Week Low
- TECH $46.01
- CRDO $18.98
- 52 Week High
- TECH $83.96
- CRDO $86.69
- Technical
- Relative Strength Index (RSI)
- TECH 39.97
- CRDO 72.12
- Support Level
- TECH $46.05
- CRDO $57.21
- Resistance Level
- TECH $49.92
- CRDO $63.66
- Average True Range (ATR)
- TECH 2.20
- CRDO 3.00
- MACD
- TECH -0.04
- CRDO 0.72
- Stochastic Oscillator
- TECH 8.74
- CRDO 89.56
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About CRDO Credo Technology Group Holding Ltd
Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.